These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28791495)

  • 1. Joint relative risks for estrogen receptor-positive breast cancer from a clinical model, polygenic risk score, and sex hormones.
    Shieh Y; Hu D; Ma L; Huntsman S; Gard CC; Leung JWT; Tice JA; Ziv E; Kerlikowske K; Cummings SR
    Breast Cancer Res Treat; 2017 Nov; 166(2):603-612. PubMed ID: 28791495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer risk prediction using a clinical risk model and polygenic risk score.
    Shieh Y; Hu D; Ma L; Huntsman S; Gard CC; Leung JW; Tice JA; Vachon CM; Cummings SR; Kerlikowske K; Ziv E
    Breast Cancer Res Treat; 2016 Oct; 159(3):513-25. PubMed ID: 27565998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
    J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex hormone measurements using mass spectrometry and sensitive extraction radioimmunoassay and risk of estrogen receptor negative and positive breast cancer: Case control study in UK Collaborative Cancer Trial of Ovarian Cancer Screening (UKCTOCS).
    Fourkala EO; Blyuss O; Field H; Gunu R; Ryan A; Barth J; Jacobs I; Zaikin A; Dawnay A; Menon U
    Steroids; 2016 Jun; 110():62-69. PubMed ID: 27091764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers.
    Farhat GN; Cummings SR; Chlebowski RT; Parimi N; Cauley JA; Rohan TE; Huang AJ; Vitolins M; Hubbell FA; Manson JE; Cochrane BB; Lane DS; Lee JS
    J Natl Cancer Inst; 2011 Apr; 103(7):562-70. PubMed ID: 21330633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study.
    Kahán Z; Gardi J; Nyári T; Földesi I; Hajnal-Papp R; Ormándi K; Lázár G; Thurzó L; Schally AV
    Int J Oncol; 2006 Jul; 29(1):193-200. PubMed ID: 16773200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
    J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex-steroid hormones and risk of postmenopausal estrogen receptor-positive breast cancer: a case-cohort analysis.
    Albers FEM; Lou MWC; Dashti SG; Swain CTV; Rinaldi S; Viallon V; Karahalios A; Brown KA; Gunter MJ; Milne RL; English DR; Lynch BM
    Cancer Causes Control; 2024 Jun; 35(6):921-933. PubMed ID: 38363402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study.
    Zhang X; Rice M; Tworoger SS; Rosner BA; Eliassen AH; Tamimi RM; Joshi AD; Lindstrom S; Qian J; Colditz GA; Willett WC; Kraft P; Hankinson SE
    PLoS Med; 2018 Sep; 15(9):e1002644. PubMed ID: 30180161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combined influence of multiple sex and growth hormones on risk of postmenopausal breast cancer: a nested case-control study.
    Tworoger SS; Rosner BA; Willett WC; Hankinson SE
    Breast Cancer Res; 2011 Oct; 13(5):R99. PubMed ID: 22017816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control study.
    James RE; Lukanova A; Dossus L; Becker S; Rinaldi S; Tjønneland A; Olsen A; Overvad K; Mesrine S; Engel P; Clavel-Chapelon F; Chang-Claude J; Vrieling A; Boeing H; Schütze M; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Krogh V; Panico S; Tumino R; Sacerdote C; Rodríguez L; Buckland G; Sánchez MJ; Amiano P; Ardanaz E; Bueno-de-Mesquita B; Ros MM; van Gils CH; Peeters PH; Khaw KT; Wareham N; Key TJ; Allen NE; Romieu I; Siddiq A; Cox D; Riboli E; Kaaks R
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1626-35. PubMed ID: 21813404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of serum sex steroid receptor bioactivity and sex steroid hormones with breast cancer risk in postmenopausal women.
    Fourkala EO; Zaikin A; Burnell M; Gentry-Maharaj A; Ford J; Gunu R; Soromani C; Hasenbrink G; Jacobs I; Dawnay A; Widschwendter M; Lichtenberg-Fraté H; Menon U
    Endocr Relat Cancer; 2012 Apr; 19(2):137-47. PubMed ID: 22199143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort.
    Sieri S; Krogh V; Bolelli G; Abagnato CA; Grioni S; Pala V; Evangelista A; Allemani C; Micheli A; Tagliabue G; Schunemann HJ; Menard S; Berrino F; Muti P
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):169-76. PubMed ID: 19124495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex steroid hormone levels in breast adipose tissue and serum in postmenopausal women.
    Falk RT; Gentzschein E; Stanczyk FZ; Garcia-Closas M; Figueroa JD; Ioffe OB; Lissowska J; Brinton LA; Sherman ME
    Breast Cancer Res Treat; 2012 Jan; 131(1):287-94. PubMed ID: 21870130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inclusion of endogenous hormone levels in risk prediction models of postmenopausal breast cancer.
    Tworoger SS; Zhang X; Eliassen AH; Qian J; Colditz GA; Willett WC; Rosner BA; Kraft P; Hankinson SE
    J Clin Oncol; 2014 Oct; 32(28):3111-7. PubMed ID: 25135988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma sex steroid hormones and breast cancer risk in Chinese women.
    Yu H; Shu XO; Shi R; Dai Q; Jin F; Gao YT; Li BD; Zheng W
    Int J Cancer; 2003 May; 105(1):92-7. PubMed ID: 12672036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
    Tamimi RM; Byrne C; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2007 Aug; 99(15):1178-87. PubMed ID: 17652278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
    J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.